REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Talentti - Labs S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Talentti - Labs S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Talentti - Labs S.A. is based in Ecuador. The head office is in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The company was established on January 14, 2019. Talentti - Labs S.A. currently employs 2 (2023) people. In its most recent financial highlights, the company reported a net sales revenue drop of 41.08% in 2023. Its’ total assets recorded a growth of 2.3%. The enterprise’s net profit margin decreased by 25.81% in 2023.

Headquarters
Solar 20 1era Etapa
Guayaquil; Guayas;

Contact Details: Purchase the Talentti - Labs S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Talentti - Labs S.A. report to view the information.
Outstanding Shares:
Purchase the Talentti - Labs S.A. report to view the information.
Registered Capital:
Purchase the Talentti - Labs S.A. report to view the information.
Incorporation Date:
January 14, 2019
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Talentti - Labs S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-41.08%▼
Total operating revenue
-41.08%▼
Operating profit (EBIT)
-97.17%▼
Net Profit (Loss) for the Period
-93.21%▼
Total assets
2.3%▲
Total equity
3.07%▲
Operating Profit Margin (ROS)
-85.38%▼
Net Profit Margin
-25.81%▼
Return on Equity (ROE)
-42.32%▼
Quick Ratio
65.99%▲
Cash Ratio
31.48%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo